| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |